Melissa Spiel DO , Eve M. Roth MD , Allison A. Merz-Herrala MD , Anna Modest PhD, MPH , Brett C. Young MD
{"title":"Communicating uncertainty with perinatal counseling: a randomized controlled trial of a multimodal curriculum for obstetrical trainees","authors":"Melissa Spiel DO , Eve M. Roth MD , Allison A. Merz-Herrala MD , Anna Modest PhD, MPH , Brett C. Young MD","doi":"10.1016/j.xagr.2025.100535","DOIUrl":"10.1016/j.xagr.2025.100535","url":null,"abstract":"<div><h3>Background</h3><div>Effective communication of uncertain prognoses is a critical skill in obstetrics. Yet few curricula exist to prepare graduate medical education trainees for these high-stakes conversations.</div></div><div><h3>Objective</h3><div>To design and evaluate a multimodal curriculum for improving obstetric trainees' communication skills when conveying uncertain prognoses.</div></div><div><h3>Methods</h3><div>In this blinded, randomized controlled trial, obstetrics residents at an academic medical center were assigned to either a standard didactic session or an intervention group receiving a structured, multimodal curriculum. The intervention included a reading assignment on the SPIKES protocol and physician empathy, an instructional video, and facilitated small-group discussion. Two weeks post-intervention, all participants engaged in a standardized patient encounter simulating a periviable diagnosis of preterm prelabor rupture of membranes. Communication performance was assessed using a structured rubric, and stress levels before and after the encounter.</div></div><div><h3>Results</h3><div>Twenty-three obstetric trainees completed the study. The intervention group demonstrated significantly higher communication scores (mean score 19.5 vs 15.5; <em>P=.</em>02) and greater use of patient-centered techniques such as acknowledging anxiety and minimizing jargon. They also reported lower stress levels during the simulation (mean 3.2 vs 4.0 on a 5-point scale, <em>P=.</em>003). Post-intervention surveys revealed improved comfort with delivering complex prognoses and responding to emotional cues.</div></div><div><h3>Conclusion</h3><div>This structured SPIKES-based curriculum significantly enhanced obstetric trainees’ communication performance and confidence in simulated counseling scenarios involving uncertain prognoses. The curriculum is feasible for integration into graduate medical education and aligns with ACGME communication competencies. These findings support broader implementation of structured communication training in obstetrics to improve both learner outcomes and patient-centered care.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100535"},"PeriodicalIF":0.0,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144564105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elizabeth Wagman BS, Matthew Pettengill PhD, Rupsa C. Boelig MD, MS, Sarah Boudova MD, PhD
{"title":"The incidence of peripartum invasive group A streptococcal infections and association with illicit drug use","authors":"Elizabeth Wagman BS, Matthew Pettengill PhD, Rupsa C. Boelig MD, MS, Sarah Boudova MD, PhD","doi":"10.1016/j.xagr.2025.100534","DOIUrl":"10.1016/j.xagr.2025.100534","url":null,"abstract":"","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100534"},"PeriodicalIF":0.0,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Husband’s involvement in maternal antenatal care and associated factors among pregnant women’s: study protocol for systematic review and meta-analysis","authors":"Aster Shiferaw MSc, Mulunesh Minale MSc","doi":"10.1016/j.xagr.2025.100532","DOIUrl":"10.1016/j.xagr.2025.100532","url":null,"abstract":"<div><h3>Background</h3><div>The evidence of husband’s involvement in maternal antenatal care (ANC) is scant and inconsistence across each study. Therefore this systematic review and meta-analysis will be to examine (1) the characteristics of published studies on husband involvement in maternal ANC; (2) estimate the nationwide magnitude of husband involvement in maternal ANC;(3) show the significant association between husband involvement in maternal ANC and reported associated factors in published articles.</div></div><div><h3>Method</h3><div>This systematic review and meta-analysis will be conducted by publishing and unpublishing articles, which will be searched online through Google Scholar, PubMed, Cochrane Library, EMBASE, HINARI, and Africa Journals. The Preferred Reporting Item for Systematic Review and Meta-Analysis (PRISMA) guideline will be used to review articles. Repeated articles will be removed by EndNote version X7.1. The data will be extracted by using the 2014 Joanna Briggs Institute Reviewers’ Manual data extraction. Critical appraisal of the studies will be done by the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) for cross-sectional studies tool. Begg-Mazumdar rank correlation tests and Egger’s regression tests will be used to check the presence of publication bias. The presence of heterogeneity will be assessed by Cochran’s Q statistics.</div></div><div><h3>Discussion</h3><div>This systematic review and meta-analysis will be the only study that investigates the magnitude and associated factors of husband’s involvement in maternal ANC. Through gathering information, the possible outcome will be to investigate and show those interested to utilize it.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100532"},"PeriodicalIF":0.0,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144549509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rasha Fadhil Abas MRCOG, CABOG, JMCOG, MSc-ART, DGO, D.MAS, MBChB, Maad Mahdi Shallal FICOG
{"title":"Predicting in vitro fertilization success: the role of hyperglycosylated human chorionic gonadotropin to beta-human chorionic gonadotropin ratio in implantation and early pregnancy outcomes at a private in vitro fertilization center in Baghdad","authors":"Rasha Fadhil Abas MRCOG, CABOG, JMCOG, MSc-ART, DGO, D.MAS, MBChB, Maad Mahdi Shallal FICOG","doi":"10.1016/j.xagr.2025.100531","DOIUrl":"10.1016/j.xagr.2025.100531","url":null,"abstract":"<div><h3>Background</h3><div>This study explores the role of human chorionic gonadotropin (hCG) isoforms in predicting implantation success and early pregnancy outcomes in in vitro fertilization (IVF) patients. Despite advances in reproductive medicine, implantation failure, and early pregnancy loss remain significant challenges. Hyperglycosylated hCG (hCG-H) facilitates trophoblast invasion and angiogenesis, while beta-hCG (β-hCG) supports progesterone production, crucial for pregnancy maintenance. This study assesses the predictive value of these biomarkers in IVF success.</div></div><div><h3>Methods</h3><div>A prospective cohort study was conducted at Al-Binuk Private IVF Center in Baghdad from January to December 2024, including 100 women aged 20 to 44 years with primary or secondary infertility and normal uterine cavities. Women with endocrine disorders or uterine abnormalities were excluded. All transferred embryos were frozen day 4 or day 5 embryos and were implanted into a prepared uterus. Serum hCG levels, including hCG-H and β-hCG, were measured 10 to 11 days after embryo transfer. Data were analyzed using SPSS, and logistic regression was performed to evaluate the predictive value of these biomarkers.</div></div><div><h3>Results</h3><div>The mean age of participants was 34.3 years, with 54% having a normal BMI. Primary infertility was more common (73%), with an average infertility duration of 5.9 years. Half of the participants underwent their first IVF attempt. Among pregnancies, 73% resulted in a single embryo, 13% in twins, and 14% experienced pregnancy failure. Higher hCG-H and β-hCG levels were significantly associated with implantation success, and an increased hCG-H to β-hCG ratio further enhanced prediction. Logistic regression showed that higher hCG levels improved implantation success, while age negatively affected outcomes.</div></div><div><h3>Conclusion</h3><div>Serum hCG-H and β-hCG levels measured postembryo transfer serve as strong predictors of IVF success. Their ratio further enhances predictive accuracy, emphasizing their role in assessing pregnancy viability. Further research is needed to refine diagnostic thresholds and enhance fertility treatment strategies.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100531"},"PeriodicalIF":0.0,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144517739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sarah A. Fischer BS , Zahra Mahamed MS , Ashley Updike BS , Briana Boachie BS , Caitriona Greene BS , Ruth Agwaze BS , Kira Parr BS , Tanzy Love PhD , Adrienne D. Bonham MD , Mitchell A. Linder MD , Megan L. Falsetta PhD
{"title":"TGF-β drives myofibroblast activation and inflammatory mediator production in vulvar lichen sclerosus","authors":"Sarah A. Fischer BS , Zahra Mahamed MS , Ashley Updike BS , Briana Boachie BS , Caitriona Greene BS , Ruth Agwaze BS , Kira Parr BS , Tanzy Love PhD , Adrienne D. Bonham MD , Mitchell A. Linder MD , Megan L. Falsetta PhD","doi":"10.1016/j.xagr.2025.100528","DOIUrl":"10.1016/j.xagr.2025.100528","url":null,"abstract":"<div><h3>Objective</h3><div>Vulvar lichen sclerosus (VLS) is a chronic inflammatory skin condition characterized by whitening of the external genitalia, debilitating pruritus (itching), and pain. As disease advances, loss of labia, burying of vulvar anatomy (ie, clitoris, urethra, vaginal opening), and vulvar cancer can occur, yet mechanistic understanding of these events remains limited. VLS lesions appear visibly similar to scars and are frequently referred to as such. Therefore, we investigated the role of fibrosis in the VLS disease mechanism with the goal of identifying targets for new therapeutic and diagnostic strategies.</div></div><div><h3>Study design</h3><div>6-mm biopsies were collected from 8 participants with VLS from regions of the vulva visibly affected by lichen sclerosus (“scarred”) and adjacent unaffected areas (“unscarred”), allowing each patient to serve as their own control thus diminishing biological noise. Specimens were also used to establish fibroblast strains, and cells were stimulated with TGF-β to assess fibroblast-to-myofibroblast transitions, extracellular matrix (ECM) production, and inflammatory responses in scarred versus unscarred areas.</div></div><div><h3>Results</h3><div>Fibroblasts from scarred areas expressed higher levels of cytoskeletal proteins (alpha-smooth muscle actin) and inflammatory mediators (interleukin 6, prostaglandin E2) upon TGF-β stimulation compared to their unscarred counterparts. Treatment with SB-431542, a TGF-β receptor inhibitor, quelled these responses (<em>P</em>≤.05), indicating that these effects are mediated through the TGF-β pathway. Fibroblasts isolated from scarred tissues exhibit myofibroblast morphologies, but so do fibroblasts from unscarred areas.</div></div><div><h3>Conclusion</h3><div>TGF-β activates myofibroblasts and exacerbates inflammation in VLS cells from scarred areas. However, fibroblasts from both scarred and unscarred areas show similarities in morphology and ECM production, suggesting molecular changes may occur in VLS skin before visible changes are detected, which could lead to new diagnostic strategies to treat disease before irreversible architectural changes occur.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100528"},"PeriodicalIF":0.0,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hannah M. Murphy BSc , Bailey P.S. Cox BSc , Heather M. Manning BSc , Zohreh Zeidy BSc , Sarah Benson MD , John D. Cullen MSc , Deanna Murphy MD , Sean Murphy MD , Sarah Healey MD , Laurie Twells PhD , Katie P. Wadden PhD
{"title":"A descriptive analysis of a fertility services waitlist in Eastern Canada","authors":"Hannah M. Murphy BSc , Bailey P.S. Cox BSc , Heather M. Manning BSc , Zohreh Zeidy BSc , Sarah Benson MD , John D. Cullen MSc , Deanna Murphy MD , Sean Murphy MD , Sarah Healey MD , Laurie Twells PhD , Katie P. Wadden PhD","doi":"10.1016/j.xagr.2025.100525","DOIUrl":"10.1016/j.xagr.2025.100525","url":null,"abstract":"<div><h3>Background</h3><div>Infertility is common and impacts quality of life. Maternal age is an important factor in fertility status, and therefore, timely access to care is critical. Long waits for specialist care remain a reality in Canada, representing an opportunity for early intervention.</div></div><div><h3>Objective</h3><div>This study aimed to characterize the population seeking infertility care in Newfoundland and Labrador (NL).</div></div><div><h3>Study Design</h3><div>A province-wide, cross-sectional analysis of referrals to Newfoundland and Labrador Fertility Services (NLFS) was conducted. Deidentified data were extracted from patient records. Descriptive analyses of the reason for referral, provincial geographical health zone, and female age, and a comparison of the age of patients referred across the province were completed. Historical live birth data were used to adjust for population differences.</div></div><div><h3>Results</h3><div>There were 317 eligible referrals received by NLFS over a 6-month period. The most common reason for referral was infertility (n=221, 70%). The overall mean age of referred females was 33.09 years (<em>SD</em>=5.03). The Eastern-Urban region had the highest number of referrals (n=145, 66%), which was greater than expected based on live birth rates (<em>P</em>≤.001). Patients referred from areas outside of the Eastern-Urban region were younger (<em>P</em>≤.001).</div></div><div><h3>Conclusion</h3><div>Infertility was the most common reason for referral. The age of females referred for infertility emphasizes the need for prompt intervention. There were differences in referral patterns across the province, including a disproportionately high referral rate in the Eastern-Urban region.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100525"},"PeriodicalIF":0.0,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144549510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bao Huy Le MD , Thao-Ngan Nguyen Pham MD , Huong-Dung Thi Nguyen MD , Tri Cuong Phan MD , Han My Nguyen Le , Thien Tan Tri Tai Truyen MD , Tam Duc Lam MD, PhD
{"title":"Burden and risk factors of cervical cancer in Vietnam from 1990 to 2021 and forecasting to 2050—a systematic analysis from global burden disease","authors":"Bao Huy Le MD , Thao-Ngan Nguyen Pham MD , Huong-Dung Thi Nguyen MD , Tri Cuong Phan MD , Han My Nguyen Le , Thien Tan Tri Tai Truyen MD , Tam Duc Lam MD, PhD","doi":"10.1016/j.xagr.2025.100526","DOIUrl":"10.1016/j.xagr.2025.100526","url":null,"abstract":"<div><h3>Background</h3><div>Cervical cancer continues to be a significant global health challenge, with Vietnam facing similar concerns. Although there has been some progress in lowering its incidence and mortality rates, a comprehensive understanding of long-term trends and the factors driving these changes remains limited.</div></div><div><h3>Objective</h3><div>This study aimed to analyze the burden and risk factors of cervical cancer in Vietnam over a 3-decade period, from 1990 to 2021 with projection to 2050.</div></div><div><h3>Study design</h3><div>Our study used data from the Global Burden of Disease (GBD) 2021 estimates, developed by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. This dataset includes metrics such as incidence, prevalence, mortality, and disability-adjusted life years (DALYs), all presented as age-standardized rates (ASRs) per 100,000 individuals. We analyzed trends from 1990 to 2021 and projections for 2022 to 2050 using the Joinpoint regression model. Additionally, we examined ASRs for death and DALYs attributed to cervical cancer-related risk factors.</div></div><div><h3>Results</h3><div>In 2021, cervical cancer accounted for approximately 4369 deaths (95% UI: 3345–5713) in Vietnam, with ASRs for incidence, prevalence, and mortality at 16.50 per 100,000 (95% UI: 12.49–21.83), 88.11 per 100,000 (95% UI: 65.32–116.75), and 7.66 per 100,000 (95% UI: 5.90–9.94), respectively. From 1990 to 2021, trends in incidence, DALYs, and mortality followed 3 phases: a decrease in incidence from 1990 to 1992 (APC: –2.42%, 95% CI: –3.56 to –0.85), an increase from 1992 to 1996 (APC: 2.69%, 95% CI: 2.09–3.65), and a subsequent decrease from 1996 to 2008 (APC: -0.68%, 95% CI: –0.86 to –0.57), with no significant change from 2008 to 2021. Projections from 2022 to 2050 suggest an all-age DALYs rate of 147.55 (95% UI: 105.14–198.31) in 2050, with an expected rise until 2039 followed by a decline, reflecting an annual percent change of –0.2% (95% CI: –0.07 to –0.55). Major risk factors for cervical cancer in Vietnam include smoking and unsafe sexual practices, with associated age-standardized mortality rates of 0.31 (95% UI: 0.16–0.53) and 7.66 (95% CI: 5.89–9.80) per year, respectively.</div></div><div><h3>Conclusion</h3><div>The study reveals that, despite some progress in reducing the incidence, mortality, and DALYs associated with cervical cancer in Vietnam over the past 3 decades, the overall burden remains substantial. This study underscores the impact of key risk factors, including smoking and unsafe sex. Future research is needed to evaluate effective interventions and healthcare policies that could reduce the burden of cervical cancer and improve women’s health outcomes in Vietnam.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100526"},"PeriodicalIF":0.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144502371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Indiscriminate antibiotic prescribing for nonspecific symptoms perpetuates gender-based healthcare inequities","authors":"Alec Szlachta-McGinn MD , Lynn Stothers MD, MHS , A. Lenore Ackerman MD, PhD","doi":"10.1016/j.xagr.2025.100524","DOIUrl":"10.1016/j.xagr.2025.100524","url":null,"abstract":"<div><div>Urinary tract infection is among the most common bacterial infection among adults, and women are significantly more likely to experience urinary tract infection than men. The prevalence of urinary tract infection in women increases with age, as does the prevalence of noninfectious lower urinary tract symptoms and asymptomatic bacterial colonization of the urinary tract, known as asymptomatic bacteriuria. Distinguishing among these 3 entities is challenging without a complete clinical evaluation, including history, physical examination, and urine culture data. Existing literature demonstrates high misclassification of nonspecific symptoms, such as urinary tract infection, among women. In addition, less than one-fifth of diagnoses meet evidence-based criteria for urinary tract infection. Therefore, women are burdened by several healthcare inequities, including delays in care for potentially life-threatening conditions, antibiotic resistance and antibiotic-associated adverse events because of overreliance on antibiotics for noninfectious symptoms, and distrust of medical care. Profit-driven pressures imposed by our healthcare system, which reward providers for increasing clinical volume at the expense of quality patient-provider interactions, are a major culprit driving these inequities. In addition, lack of provider knowledge regarding urinary tract infection–confusable diagnoses, discomfort with pelvic examinations, and inappropriate use of automated question-based algorithms to diagnose and treat urinary tract infection are to blame. An evidence-based approach incorporating a focused history and physical examination that is concordant with the patient’s chief complaint in addition to urine culture data only in cases of suspected urinary tract infection is the only way to reduce urinary tract infection–related healthcare inequities unfairly confronting women.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100524"},"PeriodicalIF":0.0,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sarah H. Abelman MD , Frank I. Jackson DO , Nathan A. Keller MD , Julie Chen BBA , Luis A. Bracero MD , Cara S. Wetcher MD , Matthew J. Blitz MD, MBA
{"title":"Ultrasound-indicated cerclage: does expedited placement prolong gestation?","authors":"Sarah H. Abelman MD , Frank I. Jackson DO , Nathan A. Keller MD , Julie Chen BBA , Luis A. Bracero MD , Cara S. Wetcher MD , Matthew J. Blitz MD, MBA","doi":"10.1016/j.xagr.2025.100523","DOIUrl":"10.1016/j.xagr.2025.100523","url":null,"abstract":"<div><h3>Background</h3><div>There is no clear consensus on the urgency of ultrasound-indicated cerclage placement after sonographic diagnosis of a short cervix, and it remains uncertain whether immediate cerclage placement prolongs gestation and improves pregnancy outcomes compared to scheduling within a reasonable timeframe.</div></div><div><h3>Objective</h3><div>This study aimed to determine whether the time interval between the sonographic diagnosis of a short cervix and transvaginal cerclage placement is associated with gestational age at delivery and preterm birth.</div></div><div><h3>Study Design</h3><div>This retrospective cohort study included all patients who received an ultrasound-indicated cerclage between January 2018 and December 2023 within a large New York health system. Patients were categorized into two groups: those with a history of preterm birth and a short cervix (<25 mm) and those with no prior preterm birth but a very short cervix (<10 mm). The primary exposure was the time interval between diagnosis of a short cervix (ie, decision for cerclage) and cerclage placement, with expedited placement defined as within 1 day for patients without prior preterm birth, and within 5 days for those with prior preterm birth. These cutoffs were determined based on the median time-to-cerclage (days) observed within our study population for each cohort and rounded to the nearest day. The primary outcome was gestational age at delivery, with secondary outcomes including latency to delivery, as well as preterm birth at <37, <34, and <32 weeks. Statistical analyses included linear mixed model regression and multivariate logistic regression, adjusting for body mass index, gestational age at diagnosis, and shortest cervical length prior to cerclage. Data were analyzed using R version 4.3.1. Statistical significance was defined as <em>P</em><.05.</div></div><div><h3>Results</h3><div>A total of 125 patients were included, with 83 having a cervical length <10 mm and no prior preterm birth, and 42 having a cervical length <25 mm with a history of preterm birth. In the group without a prior preterm birth, the mean cervical length before cerclage was 6.3±2.4 mm, and the mean gestational age at cerclage placement was 21.0±1.7 weeks. Overall, 74.7% received expedited cerclage placement (≤1 day), while 25.3% underwent routine placement. Gestational age at delivery and preterm birth rates were similar between the expedited and routine placement groups. In the group with a history of preterm birth, the mean cervical length before cerclage was 18.2±5.8 mm, with cerclage placed at a mean gestational age of 19.8±2.6 weeks. Overall, 45.2% underwent expedited placement (≤5 days), while 54.8% had routine placement. A statistically significant difference in gestational age at delivery was observed between groups (36.9±2.5 weeks vs 36.9±3.0 weeks, <em>P</em>=.04), but this difference was not clinically meaningful.</div></div><div><h3>Concl","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100523"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144472210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}